Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
NYSE:PFE
Pfizer Inc (PFE)
26.17
+0.57 (2.23%)
as of Jun 11, 2026, 8:00:00 pm Market Open.
322 watching
Financials 
Technical Analysis 0
BUY
A cheap company. The sector is cheap. Really great yield. Expects they will be getting rid of their consumer products division this year, which will give the stock a boost.
Paul Harris, CFAOwned
biotechnologypharmaceutical
BUY
Near 4% yield which is very attractive. Good level to buy. Trading at about 12 X earnings. Gives about 35% return on equity. No debt.
Laura WallaceOwned
biotechnologypharmaceutical
TOP PICK
His model price is $38, a 49% positive differential. Pays a nice fat dividend.
Brian Acker, CAOwned
biotechnologypharmaceutical
TOP PICK
Has an ace dividend yield of about 3%. Turning things around. Have a good pipeline. Has there consumer products operation up for sale but thinks they will spin it out to the shareholders. Very little downside risk.
Norman LevineOwned
biotechnologypharmaceutical
BUY
Owns Teva (TEVA-Q) as a growth stock and owns this one as a value stock. This one seems to be doing things correctly, more so than Merk (MRK-N). Feels the environment has bottomed out and will be getting better. Low risk.
Norman LevineOwned
biotechnologypharmaceutical
BUY
Likes the pharmaceutical sector. This one is very cheap. Dividend of 3.5%. Trading at 10 X earnings.
Paul Harris, CFAOwned
biotechnologypharmaceutical
BUY
The fundamental outlook is improving. The worst is behind it. The company is swimming in cash. There could be another dividend increase.
Norman LevineOwned
biotechnologypharmaceutical
BUY
Pfizer is a large cap pharma. Probably the largest pharma company in the world. Has suffered along with the rest of the industry. It is well positioned. Very attractive. Good dividend yield. Predicts it will continue to grow 12-15%.
Laura WallaceOwned
biotechnologypharmaceutical
BUY
He likes this industry. The growth is not what it used to be. Evaluations are cheaper than they have been in a long time. Growth stocks are cheaper than they have been in last 20 years.
John ZechnerOwned
biotechnologypharmaceutical
PAST TOP PICK
(A Top Pick Dec 5/05. Up 20%.) They got a positive legal ruling on Lipator which protects their patent. They increased their dividend. Have just announced that they will be doing something with their consumer product division, spinning out to shareholders or selling it.
Norman LevineOwned
biotechnologypharmaceutical
BUY
This is a value stock and is showing up under his parameters as a buy. As a strategic investor, this would be the time to buy this.
Jim O'ShaughnessyOwned
biotechnologypharmaceutical
SELL
Thinks the heyday of those large pharmaceutical companies have come and gone. The pipeline is relatively bare. They have reached a point in time when they are trying to cut costs at a greater rate than the revenue decline. Not a good business to be in at this point.
Ian NakamotoOwned
biotechnologypharmaceutical
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
